References
- Wang DY, Chan WM, Tam PO, Baum L, Lam DS, Chong KK, et al. Gene mutations in retinitis pigmentosa and their clinical implications. Clin Chim Acta 2005;351:5–16.
- Kondo M, Sakai T, Komeima K, Kurimoto Y, Ueno S, Nishizawa Y, et al. Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci 2009;50:1371–1377.
- Hirota R, Kondo M, Ueno S, Sakai T, Koyasu T, Terasaki H. Photoreceptor and post-photoreceptoral contributions to photopic ERG a-wave in rhodopsin P347L transgenic rabbits. Invest Ophthalmol Vis Sci 2012;53:1467–1472.
- Campochiaro PA, Strauss RW, Lu L, Hafiz G, Wolfson Y, Shah SM, et al. Is there excess oxidative stress and damage in eyes of patients with retinitis pigmentosa? Antioxid Redox Signal 2015;23:643–648.
- Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1–Nrf2 pathway. Trends Pharmacol Sci 2013;34:340–346.
- Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod 2011;74:537–545.
- Nakagami Y, Masuda K, Hatano E, Inoue T, Matsuyama T, Iizuka M, et al. Novel Nrf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits. Br J Pharmacol 2015;172:1237–1249.
- Kaushal S, Khorana HG. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994;33:6121–6128.
- Levonen AL, Hill BG, Kansanen E, Zhang J, Darley-Usmar VM. Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic Biol Med 2014;71:196–207.
- Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:3941–3948.
- Martínez-Fernández de la Cámara C, Salom D, Sequedo MD, Hervás D, Marín-Lambíes C, Aller E, et al. Altered antioxidant–oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One 2013;8:e74223.
- Lee SY, Usui S, Zafar AB, Oveson BC, Jo YJ, Lu L, et al. N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa. J Cell Physiol 2011;226:1843–1849.
- Usui S, Komeima K, Lee SY, Jo YJ, Ueno S, Rogers BS, et al. Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther 2009;17:778–786.
- Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol 2004;122:1306–1314.
- Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2010;128:403–411.